E-LIB Suche - Ergebnisse für: Arnason, Jon

1

Five-year follow-up of a phase 2 study of ibrutinib plus fl..:

Ahn, Inhye E. ; Brander, Danielle M. ; Ren, Yue...
Blood Advances. 8 (2024) 4 - p. 832-841 , 2024

Link: https://doi.org/10.1182/..

2

Plain language summary of the TRANSFORM study primary analy..:

Abramson, Jeremy S ; Solomon, Scott R ; Arnason, Jon...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

3

Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) with R..:

Palomba, M. Lia ; Siddiqi, Tanya ; Gordon, Leo I....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S14 , 2024

Link: https://doi.org/10.1016/..

4

Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and..:

Hasan, Haytham ; Surjancev, Ivana ; Arnason, Jon A....
Case Reports in Rheumatology. 2023 (2023) - p. 1-5 , 2023

Link: https://doi.org/10.1155/..

5

2694. Infectious Complications in CAR-T Cell Therapy Recipi..:

Banegas, Marcela ; Bindal, Poorva ; Woodbine, Maria Jose Hernandez...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

6

POSTER: MCL-096 Lisocabtagene Maraleucel (Liso-Cel) in R/R ..:

Palomba, M. Lia ; Siddiqi, Tanya ; Gordon, Leo I....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S213 , 2023

Link: https://doi.org/10.1016/..

7

Targeting CD19 for diffuse large B cell lymphoma in the era..:

Sermer, David ; Elavalakanar, Pavania ; Abramson, Jeremy S....
Blood Reviews. 57 (2023) - p. 101002 , 2023

Link: https://doi.org/10.1016/..

8

Lisocabtagene maraleucel as second-line therapy for large B..:

Abramson, Jeremy S. ; Solomon, Scott R. ; Arnason, Jon...
Blood. 141 (2023) 14 - p. 1675-1684 , 2023

Link: https://doi.org/10.1182/..

9

MCL-096 Lisocabtagene Maraleucel (Liso-Cel) in R/R MCL: Pri..:

Palomba, M. Lia ; Siddiqi, Tanya ; Gordon, Leo I....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S458 , 2023

Link: https://doi.org/10.1016/..

10

Clonal myeloid disorders following CAR T-cell therapy:

Andersen Jr, Michael ; Bindal, Poorva ; Michaels, Phillip...
Annals of Hematology. 102 (2023) 12 - p. 3643-3645 , 2023

Link: https://doi.org/10.1007/..

11

Primary Analysis (PA) Results from the Randomized, Phase 3 ..:

Abramson, Jeremy S. ; Solomon, Scott R. ; Arnason, Jon...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S36-S37 , 2023

Link: https://doi.org/10.1016/..

12

Health-related quality of life with lisocabtagene maraleuce..:

Abramson, Jeremy S. ; Johnston, Patrick B. ; Kamdar, Manali...
Blood Advances. 6 (2022) 23 - p. 5969-5979 , 2022

Link: https://doi.org/10.1182/..

13

Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel..:

Siddiqi, Tanya ; Soumerai, Jacob D. ; Dorritie, Kathleen A....
Blood. 139 (2022) 12 - p. 1794-1806 , 2022

Link: https://doi.org/10.1182/..

14

Complete responses to odronextamab in two patients with dif..:

Weinstock, Matt ; Elavalakanar, Pavania ; Bright, Susan...
British Journal of Haematology. 199 (2022) 3 - p. 366-370 , 2022

Link: https://doi.org/10.1111/..

15

Lisocabtagene maraleucel versus standard of care with salva..:

Kamdar, Manali ; Solomon, Scott R ; Arnason, Jon...
The Lancet. 399 (2022) 10343 - p. 2294-2308 , 2022

Link: https://doi.org/10.1016/..